Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

LZI Buprenorphine II Enzyme Immunoassay

K-Number: K253082 · 2026-01-16

Decision Date2026-01-16
Product CodeDJG
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

LZI Buprenorphine II Enzyme Immunoassay is a medical device manufactured by Lin-Zhi International, Inc.. It received FDA 510(k) clearance on 2026-01-16 under approval number K253082. The device is classified under product code DJG. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the LZI Buprenorphine II Enzyme Immunoassay?

LZI Buprenorphine II Enzyme Immunoassay is a medical device that received FDA 510(k) clearance on 2026-01-16. It is manufactured by Lin-Zhi International, Inc.. The 510(k) number is K253082.

When was LZI Buprenorphine II Enzyme Immunoassay approved by the FDA?

LZI Buprenorphine II Enzyme Immunoassay received FDA 510(k) clearance on 2026-01-16, under approval number K253082.

What company makes LZI Buprenorphine II Enzyme Immunoassay?

LZI Buprenorphine II Enzyme Immunoassay is manufactured by Lin-Zhi International, Inc..

What is the FDA product code for LZI Buprenorphine II Enzyme Immunoassay?

The FDA product code for LZI Buprenorphine II Enzyme Immunoassay is DJG.

Other Devices by Lin-Zhi International, Inc.

View all 10 devices →

Related Devices (Code: DJG)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.